CVE-2026-21974

Katalog CVE

CVSS 5.3 · Medium EPSS 0,25%

Kerentanan Exposure of Sensitive Information to an Unauthorized Actor pada oracle life sciences central designer. Skor CVSS 3.1 5.3 (Medium) menurut oracle.com.

Deskripsi (NVD)

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Rincian

Terbit di NVD

20 Januari 2026

Terakhir diubah

17 Juni 2026

Status NVD

Analyzed

CVSS 3.1

5.3 (Medium), sumber oracle.com
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N · uraikan di kalkulator

Jenis kelemahan (CWE)

CWE-200: Exposure of Sensitive Information to an Unauthorized Actor

EPSS (30 hari)

0,25% peluang dieksploitasi; lebih tinggi dari 15,0% CVE lain

Produk dan versi terdampak

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

• https://www.oracle.com/security-alerts/cpujan2026.html advisory vendor